APA (7th ed.) Citation

Hoshi, T., Sato, A., Nogami, A., Gosho, M., & Aonuma, K. (2017). Rationale and design of the SAFE-A study: SAFety and Effectiveness trial of Apixaban use in association with dual antiplatelet therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention. Journal of cardiology, 69(4), 648-651. https://doi.org/10.1016/j.jjcc.2016.06.007

Chicago Style (17th ed.) Citation

Hoshi, Tomoya, Akira Sato, Akihiko Nogami, Masahiko Gosho, and Kazutaka Aonuma. "Rationale and Design of the SAFE-A Study: SAFety and Effectiveness Trial of Apixaban Use in Association with Dual Antiplatelet Therapy in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention." Journal of Cardiology 69, no. 4 (2017): 648-651. https://doi.org/10.1016/j.jjcc.2016.06.007.

MLA (9th ed.) Citation

Hoshi, Tomoya, et al. "Rationale and Design of the SAFE-A Study: SAFety and Effectiveness Trial of Apixaban Use in Association with Dual Antiplatelet Therapy in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention." Journal of Cardiology, vol. 69, no. 4, 2017, pp. 648-651, https://doi.org/10.1016/j.jjcc.2016.06.007.